Disparities in Diabetes

Drs. Julie Schulz and Michael Dovidio on Using Lab Values for GLP-1 Drug Coverage
Julie Schulz, MD, MPH, Physician Executive,  Product leader, and VP of Product, and Michael Dovidio, PharmD, Product Manager at Avalon Healthcare Solutions, discuss why leveraging cardiometabolic lab values instead of BMI to determine coverage for GLP-1 drugs would improve prescription allocation for diabetic and obese patients. ...
Advertisement
Advertisement

Expert Interviews

Advertisement
Advertisement
Latest News

November 28, 2024